XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net sales $ 951 $ 947 $ 2,888 $ 2,953
Cost of products sold 456 452 1,376 1,389
Gross profit 495 495 1,512 1,564
Selling, general, and administrative expenses 390 372 1,204 1,204
Research and development expenses 40 46 123 141
Goodwill and intangible asset impairments 504 307 510 307
Restructuring and other costs 23 6 45 70
Operating loss (462) (236) (370) (158)
Other income and expenses:        
Interest expense, net 18 19 53 61
Other (income) expense, net (2) (5) (10) 13
Loss before income taxes (478) (250) (413) (232)
Provision (benefit) for income taxes 17 16 69 (28)
Net loss (495) (266) (482) (204)
Less: Net loss attributable to noncontrolling interests (1) 0 (2) (5)
Net loss attributable to Dentsply Sirona $ (494) $ (266) $ (480) $ (199)
Loss per common share attributable to Dentsply Sirona:        
Basic (in dollars per share) $ (2.46) $ (1.25) $ (2.35) $ (0.94)
Diluted (in dollars per share) $ (2.46) $ (1.25) $ (2.35) $ (0.94)
Weighted average common shares outstanding:        
Basic (in shares) 201.0 211.8 204.7 212.7
Diluted (in shares) 201.0 211.8 204.7 212.7